Protalix BioTherapeutics Competitors and Similar CompaniesClear all

Pharming Group's competitors and similar companies include UCB and Genentech.

	Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 1988	Founding Date 1928	Founding Date 1976
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Leiden, NL HQ Leiden, NL	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 404	Employees 9,052	Employees 18,077
Valuation ($)	Valuation ($) 590.3 m	Valuation ($) 34.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $376.1m (FY, 2025)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $41.6m (FY, 2025)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $341m (FY, 2025)	Gross profit €7.2b (FY, 2025)	Gross profit N/A
Net income	Net income $2.5m (FY, 2025)	Net income €1.6b (FY, 2025)	Net income N/A
Operating ⚠
Phase I Trials Products	Phase I Trials Products 2 (Q3, 2020)	Phase I Trials Products N/A	Phase I Trials Products 28 (Jul, 2025)
Phase II Trials Products	Phase II Trials Products 1 (Q3, 2020)	Phase II Trials Products N/A	Phase II Trials Products 19 (Jul, 2025)